XML 57 R45.htm IDEA: XBRL DOCUMENT v3.24.3
Segment Information - Sales And Other Financial Information By Business Segment (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Segment Reporting Information [Line Items]        
Net sales $ 5,494 $ 4,909 $ 16,159 $ 14,683
Segment operating income 1,085 931 3,108 2,631
Amortization of intangible assets (159) (164) (467) (486)
MedSurg and Neurotechnology:        
Segment Reporting Information [Line Items]        
Net sales 3,224 2,859    
Orthopaedics and Spine:        
Segment Reporting Information [Line Items]        
Net sales 2,270 2,050 6,819 6,274
Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 5,494 4,909 16,159 14,683
Segment operating income 1,567 1,358 4,513 3,967
Operating Segments | MedSurg and Neurotechnology:        
Segment Reporting Information [Line Items]        
Net sales 3,224 2,859 9,340 8,409
Segment operating income 924 859 2,589 2,266
Operating Segments | Orthopaedics and Spine:        
Segment Reporting Information [Line Items]        
Net sales 2,270 2,050 6,819 6,274
Segment operating income 643 499 1,924 1,701
Corporate and other        
Segment Reporting Information [Line Items]        
Segment operating income (210) (209) (676) (596)
Segment Reconciling Items        
Segment Reporting Information [Line Items]        
Acquisition and integration-related costs (77) 1 (87) (7)
Amortization of intangible assets (159) (164) (467) (486)
Structural optimization and other special charges (24) (28) (113) (142)
Medical device regulations (13) (19) (41) (74)
Recall-related matters 0 (9) (22) (12)
Regulatory and legal matters $ 1 $ 1 $ 1 $ (19)